Skip to main content

Anthony Petrone

Stock Analyst at Mizuho Securities

Total Price Targets
41
Stocks Covered
23
Sectors
Healthcare, Technology
Most Recent
Apr 13, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • ADMA+132.3%
    ADMA Biologics, Inc.
    $24.00 targetApr 13, 2026
  • INSP+49.2%
    Inspire Medical Systems, Inc.
    $110.00 targetNov 4, 2025
  • DXCM+38.3%
    DexCom, Inc.
    $90.00 targetFeb 13, 2026

Most Bearish

  • TNDM-7.1%
    Tandem Diabetes Care, Inc.
    $21.00 targetDec 17, 2025
  • RMD+11.7%
    ResMed Inc.
    $255.00 targetApr 13, 2026
  • LIVN+14.1%
    LivaNova PLC
    $72.00 targetDec 17, 2025

Stocks Covered by Anthony Petrone

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
LNTHLantheus Holdings, Inc.$95.00$85.69+10.9%2Apr 13, 2026
ADMAADMA Biologics, Inc.$24.00$10.47+129.1%2Apr 13, 2026
RMDResMed Inc.$255.00$205.50+24.1%3Apr 13, 2026
HAEHaemonetics Corporation$70.00$59.65+17.4%1Apr 13, 2026
DXCMDexCom, Inc.$90.00$61.51+46.3%2Feb 13, 2026
ABTAbbott Laboratories$125.00$89.76+39.3%1Jan 23, 2026
LIVNLivaNova PLC$72.00$61.04+18.0%2Dec 17, 2025
TNDMTandem Diabetes Care, Inc.$21.00$19.34+8.6%1Dec 17, 2025
INSPInspire Medical Systems, Inc.$110.00$57.23+92.2%1Nov 4, 2025
ISRGIntuitive Surgical, Inc.$575.00$459.71+25.1%3Oct 22, 2025
TFXTeleflex Incorporated$155.00$121.84+27.2%1Apr 16, 2025
MDXGMiMedx Group, Inc.$16.00$3.63+340.2%1Nov 15, 2024
HOLXHologic, Inc.$87.00$76.01+14.5%3Nov 5, 2024
MDTMedtronic plc$98.00$80.42+21.9%2Aug 21, 2024
ESTAEstablishment Labs Holdings Inc.$70.00$69.67+0.5%2Jun 6, 2024
ALCAlcon Inc.$105.00$74.45+41.0%2May 16, 2024
GEHCGE HealthCare Technologies Inc.$105.00$61.13+71.8%2May 1, 2024
BSXBoston Scientific Corporation$85.00$56.91+49.4%4Apr 25, 2024
EWEdwards Lifesciences Corporation$105.00$84.24+24.6%2Apr 11, 2024
FFIVF5, Inc.$190.00$322.58-41.1%1Apr 11, 2024
COOThe Cooper Companies, Inc.$110.00$62.51+76.0%1Aug 28, 2023
ZBHZimmer Biomet Holdings, Inc.$175.00$83.24+110.2%1Nov 5, 2021
IARTIntegra LifeSciences Holdings Corporation$86.00$10.85+692.6%1May 20, 2021

Recent Activity

  • Apr 13, 2026— Set$70.00price target onHAE(Haemonetics Corporation)
  • Apr 13, 2026— Set$255.00price target onRMD(ResMed Inc.)
  • Apr 13, 2026— Set$24.00price target onADMA(ADMA Biologics, Inc.)
  • Apr 13, 2026— Set$95.00price target onLNTH(Lantheus Holdings, Inc.)
  • Feb 13, 2026— Set$90.00price target onDXCM(DexCom, Inc.)
  • Jan 23, 2026— Set$125.00price target onABT(Abbott Laboratories)
  • Dec 17, 2025— Set$21.00price target onTNDM(Tandem Diabetes Care, Inc.)
  • Dec 17, 2025— Set$72.00price target onLIVN(LivaNova PLC)
  • Nov 4, 2025— Set$110.00price target onINSP(Inspire Medical Systems, Inc.)
  • Oct 22, 2025— Set$575.00price target onISRG(Intuitive Surgical, Inc.)
  • Apr 16, 2025— Set$265.00price target onRMD(ResMed Inc.)
  • Apr 16, 2025— Set$155.00price target onTFX(Teleflex Incorporated)
  • Nov 15, 2024— Set$16.00price target onMDXG(MiMedx Group, Inc.)
  • Nov 5, 2024— Set$87.00price target onHOLX(Hologic, Inc.)
  • Oct 31, 2024— Set$70.00price target onLIVN(LivaNova PLC)
  • Oct 18, 2024— Set$550.00price target onISRG(Intuitive Surgical, Inc.)
  • Oct 4, 2024— Set$90.00price target onHOLX(Hologic, Inc.)
  • Aug 21, 2024— Set$98.00price target onMDT(Medtronic plc)
  • Jul 12, 2024— Set$165.00price target onLNTH(Lantheus Holdings, Inc.)
  • Jun 20, 2024— Set$14.00price target onADMA(ADMA Biologics, Inc.)

Frequently Asked Questions

Who is Anthony Petrone?

Anthony Petrone is a stock analyst at Mizuho Securities covering 23 stocks primarily in Healthcare, Technology. They have issued 41 price targets since May 20, 2021.

What stocks does Anthony Petrone cover?

Anthony Petrone currently covers 23 stocks, including BSX, RMD, ISRG, HOLX, LNTH.

What is Anthony Petrone's latest price target?

Anthony Petrone's most recent price target was $70.00 on HAE (Haemonetics Corporation), set on Apr 13, 2026.

What is Anthony Petrone's highest price target?

Anthony Petrone's highest issued price target is $575.00 on ISRG, set on Oct 22, 2025.

Coverage based on publicly published price targets. Not investment advice.